HCA insider transaction filings
HCA Healthcare, Inc. — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-05-11. Screen HCA transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-05-11 | 4 | Marks Mike A — EVP and CFO | Gift (G): 3,336 @ $0 · Gift (G): 3,336 @ $0 | EDGAR |
| 2026-04-30 | 4 | Smith Andrea B — Director | Grant/award (A): 509 @ $0 | EDGAR |
| 2026-04-30 | 4 | Frist William R — Director, 10% owner | Grant/award (A): 809 @ $0 | EDGAR |
| 2026-04-30 | 4 | Riley Wayne Joseph — Director | Grant/award (A): 509 @ $0 | EDGAR |
| 2026-04-30 | 4 | Johnston Hugh F — Director | Grant/award (A): 809 @ $0 | EDGAR |
| 2026-04-30 | 4 | FRIST THOMAS F III — Director, 10% owner | Grant/award (A): 1,041 @ $0 | EDGAR |
| 2026-04-30 | 4 | MICHELSON MICHAEL W — Director | Grant/award (A): 925 @ $0 | EDGAR |
| 2026-04-30 | 4 | DEPARLE NANCY ANN — Director | Grant/award (A): 509 @ $0 | EDGAR |
| 2026-04-30 | 4 | CHIDSEY JOHN — Director | Grant/award (A): 809 @ $0 | EDGAR |
| 2026-02-18 | 4 | McAlevey Michael R — EVP & Chief Legal & Admin Off. | Option exercise (M): 5,000 @ $236.61 · Tax withholding (F): 3,306 @ $540.29 · Sale (S): 1,694 @ $533.37 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2026-02-12 | 4 | Rossitto Erica — SVP & Chief Nurse Executive | Grant/award (A): 1,676 @ $0 · Tax withholding (F): 418 @ $502.05 | EDGAR |
| 2026-02-12 | 4 | Marks Mike A — EVP and CFO | Grant/award (A): 5,026 @ $0 · Tax withholding (F): 1,690 @ $502.05 | EDGAR |
| 2026-02-12 | 4 | McAlevey Michael R — EVP & Chief Legal & Admin Off. | Grant/award (A): 8,372 @ $0 · Tax withholding (F): 3,006 @ $502.05 | EDGAR |
| 2026-02-12 | 4 | Berres Jennifer — SVP & Chief Human Res. Officer | Grant/award (A): 7,116 @ $0 · Tax withholding (F): 2,515 @ $502.05 · Sale (S): 4,010 @ $503 · Sale (S): 4,010 @ $526.16 | EDGAR |
| 2026-02-12 | 4 | Wyatt Christopher F. — SVP & Controller | Grant/award (A): 3,350 @ $0 · Tax withholding (F): 1,034 @ $502.05 · Sale (S): 4,000 @ $505 | EDGAR |
| 2026-02-12 | 4 | Cuffe Michael S. — EVP and Chief Clinical Officer | Grant/award (A): 9,628 @ $0 · Tax withholding (F): 3,501 @ $502.05 | EDGAR |
| 2026-02-12 | 4 | Foster Jon M — EVP and COO | Grant/award (A): 15,696 @ $0 · Tax withholding (F): 5,888 @ $502.05 | EDGAR |
| 2026-02-12 | 4 | HAZEN SAMUEL N — CEO, Director | Grant/award (A): 54,934 @ $0 · Tax withholding (F): 21,323 @ $502.05 | EDGAR |
| 2026-02-10 | 4 | FRIST THOMAS F JR — 10% owner | Other (J): 36,629,188 · Other (J): 36,557,141 | EDGAR |
| 2026-02-10 | 4 | Frist William R — Director, 10% owner | Other (J): 36,629,188 · Other (J): 36,557,141 | EDGAR |
| 2026-02-10 | 4 | Elcan Patricia F — 10% owner | Other (J): 36,629,188 · Other (J): 36,557,141 | EDGAR |
| 2026-02-10 | 4 | Frisco Holding II — 10% owner | Other (J): 36,629,188 · Other (J): 36,557,141 | EDGAR |
| 2026-02-10 | 4 | HERCULES HOLDING II — 10% owner | Other (J): 36,629,188 @ $0 | EDGAR |
| 2026-02-10 | 4 | FRIST THOMAS F III — Director, 10% owner | Other (J): 36,629,188 · Other (J): 36,557,141 | EDGAR |
| 2026-02-09 | 4 | Wyatt Christopher F. — SVP & Controller | Option exercise (M): 10,670 @ $139.06 · Tax withholding (F): 5,674 @ $513.76 · Option exercise (M): 10,670 (derivative) @ $0 | EDGAR |
| 2026-02-09 | 4 | Foster Jon M — EVP and COO | Option exercise (M): 29,330 @ $139.06 · Tax withholding (F): 16,076 @ $513.76 · Option exercise (M): 29,330 (derivative) @ $0 | EDGAR |
| 2026-02-05 | 4 | Cuffe Michael S. — EVP and Chief Clinical Officer | Sale (S): 1,500 @ $498.09 · Gift (G): 4,050 @ $0 | EDGAR |
| 2026-02-05 | 4 | HAZEN SAMUEL N — CEO, Director | Sale (S): 14,716 @ $502.95 · Sale (S): 5,002 @ $502.15 · Sale (S): 7,395 @ $500.69 · Sale (S): 6,189 @ $500.02 · Sale (S): 5,162 @ $498.80 · Sale (S): 4,293 @ $498.12 · +3 more | EDGAR |
| 2026-02-02 | 4 | Marks Mike A — EVP and CFO | Grant/award (A): 11,945 (derivative) @ $0 | EDGAR |
| 2026-02-02 | 4 | McAlevey Michael R — EVP & Chief Legal & Admin Off. | Grant/award (A): 8,067 (derivative) @ $0 | EDGAR |
| 2026-02-02 | 4 | Berres Jennifer — SVP & Chief Human Res. Officer | Grant/award (A): 6,206 (derivative) @ $0 | EDGAR |
| 2026-02-02 | 4 | Wyatt Christopher F. — SVP & Controller | Grant/award (A): 2,560 (derivative) @ $0 | EDGAR |
| 2026-02-02 | 4 | Cuffe Michael S. — EVP and Chief Clinical Officer | Grant/award (A): 8,067 (derivative) @ $0 | EDGAR |
| 2026-02-02 | 4 | Foster Jon M — EVP and COO | Grant/award (A): 11,945 (derivative) @ $0 | EDGAR |
| 2026-02-02 | 4 | HAZEN SAMUEL N — CEO, Director | Option exercise (M): 84,360 @ $81.96 · Tax withholding (F): 41,483 @ $488.27 · Grant/award (A): 55,846 (derivative) @ $0 · Option exercise (M): 84,360 (derivative) @ $0 | EDGAR |
| 2025-11-18 | 4 | HAZEN SAMUEL N — CEO, Director | Gift (G): 14,830 @ $0 | EDGAR |
| 2025-11-05 | 4 | Marks Mike A — EVP and CFO | Gift (G): 165 @ $0 · Gift (G): 165 @ $0 · Gift (G): 165 @ $0 | EDGAR |
| 2025-11-05 | 4 | McAlevey Michael R — EVP & Chief Legal & Admin Off. | Option exercise (M): 13,170 @ $236.61 · Tax withholding (F): 9,278 @ $461.56 · Sale (S): 3,892 @ $473.79 · Option exercise (M): 13,170 (derivative) @ $0 | EDGAR |
| 2025-11-04 | 4 | HAZEN SAMUEL N — CEO, Director | Option exercise (M): 58,050 @ $69.58 · Tax withholding (F): 28,173 @ $459.68 · Option exercise (M): 58,050 (derivative) @ $0 | EDGAR |
| 2025-09-08 | 4 | Cuffe Michael S. — EVP and Chief Clinical Officer | Option exercise (M): 10,920 @ $173.12 · Tax withholding (F): 7,084 @ $411.59 · Sale (S): 3,836 @ $418.84 · Option exercise (M): 10,920 (derivative) @ $0 | EDGAR |
| 2025-07-31 | 4 | CHIDSEY JOHN — Director | Grant/award (A): 496 @ $0 | EDGAR |
| 2025-05-15 | 4 | Foster Jon M — EVP and COO | Sale (S): 15,698 @ $369.32 · Gift (G): 1,080 @ $0 · Gift (G): 1,080 @ $0 · Gift (G): 2,075 @ $0 · Gift (G): 2,075 @ $0 · Other (J): 15,925 @ $367.19 · +1 more | EDGAR |
| 2025-05-15 | 4 | HAZEN SAMUEL N — CEO, Director | Gift (G): 90,076 @ $0 · Gift (G): 90,076 @ $0 | EDGAR |
| 2025-05-08 | 4 | Marks Mike A — EVP and CFO | Gift (G): 466 @ $0 · Gift (G): 466 @ $0 · Other (J): 288 @ $353.57 · Other (J): 288 @ $353.57 · Gift (G): 144 @ $0 · Gift (G): 181 @ $0 · +4 more | EDGAR |
| 2025-05-01 | 4 | Smith Andrea B — Director | Grant/award (A): 645 @ $0 | EDGAR |
| 2025-05-01 | 4 | Frist William R — Director, 10% owner | Grant/award (A): 1,026 @ $0 · Other (J): 10,504.56 @ $340.60 | EDGAR |
| 2025-05-01 | 4 | Riley Wayne Joseph — Director | Grant/award (A): 645 @ $0 | EDGAR |
| 2025-05-01 | 4 | Johnston Hugh F — Director | Grant/award (A): 1,026 @ $0 | EDGAR |
| 2025-05-01 | 4 | Dennis Robert J — Director | Grant/award (A): 1,026 @ $0 | EDGAR |
| 2025-05-01 | 4 | FRIST THOMAS F III — Director, 10% owner | Grant/award (A): 1,320 @ $0 | EDGAR |
Recent 8-K events — HCA Healthcare, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-07-29 | 8-K | 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 8.01 — Other Events | EDGAR |
| 2026-07-24 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-14 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-18 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-04-30 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-28 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-04-27 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-24 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-25 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-27 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=HCA returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →